AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
+1.45%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$4.3B
AUM Growth
+$476M
(+12%)
Cap. Flow
+$486M
Cap. Flow
% of AUM
11.31%
Top 10 Holdings %
Top 10 Hldgs %
29.76%
Holding
319
New
63
Increased
77
Reduced
60
Closed
90
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$97M |
| 2 |
Exact Sciences
EXAS
|
$90.9M |
| 3 |
Icon
ICLR
|
$87.7M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$71.6M |
| 5 |
GSK
GSK
|
$62.7M |
Top Sells
| 1 |
Alkermes
ALKS
|
$40.5M |
| 2 |
PTC Therapeutics
PTCT
|
$38.7M |
| 3 |
Shake Shack
SHAK
|
$34.8M |
| 4 |
Incyte
INCY
|
$29.6M |
| 5 |
Cytokinetics
CYTK
|
$27.5M |
Sector Composition
| 1 | Healthcare | 67.09% |
| 2 | Consumer Discretionary | 10.89% |
| 3 | Consumer Staples | 9.15% |
| 4 | Technology | 8.92% |
| 5 | Communication Services | 1.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Estee Lauder
EL
$32.1B
| – | – |
-184,472
| Closed | -$18.4M |
|
252
Eledon Pharmaceuticals
ELDN
$162M
| – | – |
-2,364,000
| Closed | -$5.89M |
|
253
Enanta Pharmaceuticals
ENTA
$189M
| – | – |
-1,000,000
| Closed | -$10.4M |
|
254
Evolus
EOLS
$495M
| – | – |
-360,000
| Closed | -$5.83M |
|
255
Mobix Labs
MOBX
$58.2M
| – | – |
-2,336,000
| Closed | -$2.48M |
|
256
Mega Matrix
MPU
$103M
| – | – |
-220,000
| Closed | -$222K |
|
257
Merck
MRK
$212B
| – | – |
-182,794
| Closed | -$20.8M |
|
258
Murphy USA
MUSA
$7.47B
| – | – |
-6,592
| Closed | -$3.25M |
|
259
My Size
MYSZ
$4.17M
| – | – |
-78,000
| Closed | -$131K |
|
260
Nike
NKE
$109B
| – | – |
-17,986
| Closed | -$1.59M |
|
261
Okta
OKTA
$16.1B
| – | – |
-4,139
| Closed | -$308K |
|
262
Ondas Holdings
ONDS
$1.55B
| – | – |
-4,750,000
| Closed | -$3.66M |
|
|
PARA
263
DELISTED
Paramount Global Class B
PARA
| – | – |
-2,000,000
| Closed | -$21.2M |
|
264
Paylocity
PCTY
$9.62B
| – | – |
-1,424
| Closed | -$235K |
|
265
Procter & Gamble
PG
$375B
| – | – |
-3,017
| Closed | -$523K |
|
266
P3 Health Partners
PIII
$28.7M
| – | – |
-133,000
| Closed | -$2.57M |
|
|
PPBT
267
Purple Biotech
PPBT
$1.75M
| – | – |
-158,000
| Closed | -$877K |
|
268
Rani Therapeutics
RANI
$24.1M
| – | – |
-2,574,000
| Closed | -$5.56M |
|
269
Roblox
RBLX
$88.5B
| – | – |
-5,546
| Closed | -$245K |
|
270
Cartesian Therapeutics
RNAC
$277M
| – | – |
-98,565
| Closed | -$1.59M |
|
271
Revvity
RVTY
$10.1B
| – | – |
-107,486
| Closed | -$13.7M |
|
272
Safe & Green Holdings
SGBX
$1.56M
| – | – |
-61,000
| Closed | -$58.3K |
|
273
Sherwin-Williams
SHW
$92.9B
| – | – |
-723
| Closed | -$276K |
|
274
SPDR S&P 500 ETF Trust
SPY
$660B
| – | – |
0
| – | – |
|
275
Molson Coors Class B
TAP
$9.96B
| – | – |
-5,836
| Closed | -$336K |
|